Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page content and layout appear unchanged between screenshots, with no additions or removals affecting the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check24 days agoChange DetectedUpdated core results content and data-sharing details have been added (new survival metrics, definitions, IPD sharing plans, and contact information), while older result-status language and some outdated items were removed.SummaryDifference16%

- Check32 days agoChange DetectedMajor updates include a government funding status notice and an OS update to v3.2.0; the previous v3.1.0 tag was removed.SummaryDifference3%

- Check39 days agoChange DetectedUpdated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new release version.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, replacing the old version tag with the new one. The 'Back to Top' item was removed, representing a minor UI tweak.SummaryDifference0.2%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.